학술논문
Dual anti-viral treatment for persistent COVID-19 in immunocompromised hemato-oncological patients is associated with a favorable prognosis and minor side effects
Document Type
Article
Author
Meijer, S.E.; Halutz, O.; Adler, A.; Levytskyi, K.; Tau, L.; Dekel, M.; Katchman, E.; Shasha, D.; Ablin, J.; Jacob, G.; Wasserman, A.; Ingbir, M.; Cohen, Y.C.; Perry, C.; Ram, R.; Herishanu, Y.; Ben-Ami, R.; Paran, Y.; Cohen-Poradosu, R.; Rutsinsky, N.; Harari, S.; Stern, A.; Choshen, G.; Bar On, Y.; van Thijn, E.
Source
In: Journal of Infection and Chemotherapy . (Journal of Infection and Chemotherapy, March 2024, 30(3):271-275)
Subject
Language
English
ISSN
14377780
1341321X
1341321X